TAPP Signs Coalition Letter Opposing U.K. Proposal on Standard-Essential Patents (SEPs)

The Trade Alliance to Promote Prosperity has joined a coalition of over two dozen conservative organizations in signing a letter to President Trump, opposing a regulatory change proposed by the United Kingdom Intellectual Property Office (UK IPO). If adopted, the UK IPO’s provisions would significantly threaten U.S. leadership in critical technologies—including artificial intelligence and 6G wireless—in which standardization is central…

Read More
Ainsley Shea
TAPP in DC Journal: On Drugs, Is Trump Tired of Winning or What?

Trade Alliance to Promote Prosperity Executive Director Kent Kaiser, Ph.D., penned an op-ed for the DC Journal/Inside Sources today, “On Drugs, Is Trump Tired of Winning or What?” In the op-ed, TAPP explains why President Trump’s Most-Favored-Nation drug pricing scheme would be bad for American pharmaceutical innovation and for patients…

Read More
Ainsley Shea
TAPP Urges Lawmakers to Support PBM Reforms

On Thursday, July 24, the Justice Department’s Antitrust Division and the Federal Trade Commission, along with the Department of Commerce and the Department of Health and Human Services, hosted their second of three listening sessions as part of implementing President Trump’s Executive Order No. 14273, Lowering Drug Prices by Once Again Putting Americans First…

Read More
Ainsley Shea
TAPP Responds to USTR “Request for Comments Regarding Foreign Nations Freeloading on American-Financed Innovation”

The Trade Alliance to Promote Prosperity recently responded to the U.S. Trade Representative’s “Request for Comments Regarding Foreign Nations Freeloading on American-Financed Innovation,” which the USTR issued pursuant Executive Order 14297, titled Delivering Most-Favored-Nation (MFN) Prescription Drug Pricing to American Patients. TAPP took the opportunity to highlight the detrimental effects of implementing an MFN scheme…

Read More
Ainsley Shea